These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 24910238)

  • 1. Direct and rapid transcript analysis assay for CYP mRNA expression and inducibility in human primary hepatocytes.
    Mattinen L; Kublbeck J; Rechardt O; Honkakoski P; Rautio J
    Drug Metab Lett; 2014; 8(2):77-87. PubMed ID: 24910238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An 'all-inclusive' 96-well cytochrome P450 induction method: measuring enzyme activity, mRNA levels, protein levels, and cytotoxicity from one well using cryopreserved human hepatocytes.
    Halladay JS; Wong S; Khojasteh SC; Grepper S
    J Pharmacol Toxicol Methods; 2012; 66(3):270-5. PubMed ID: 22809809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous assessment of cytochrome P450 activity in cultured human hepatocytes for compound-mediated induction of CYP3A4, CYP2B6, and CYP1A2.
    Rhodes SP; Otten JN; Hingorani GP; Hartley DP; Franklin RB
    J Pharmacol Toxicol Methods; 2011; 63(3):223-6. PubMed ID: 21111054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient assessment of the utility of immortalized Fa2N-4 cells for cytochrome P450 (CYP) induction studies using multiplex quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) and substrate cassette methodologies.
    Kenny JR; Chen L; McGinnity DF; Grime K; Shakesheff KM; Thomson B; Riley R
    Xenobiotica; 2008 Dec; 38(12):1500-17. PubMed ID: 18989830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semi-automatic quantitative RT-PCR to measure CYP induction by drugs in human hepatocytes.
    Pérez G; Tabares B; Jover R; Gómez-Lechón MJ; Castell JV
    Toxicol In Vitro; 2003; 17(5-6):643-9. PubMed ID: 14599457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P450 1A2 Messenger RNA is a More Reliable Marker than Cytochrome P450 1A2 Activity, Phenacetin O-Deethylation, for Assessment of Induction Potential of Drug-Metabolizing Enzymes Using HepaRG Cells.
    Ogasawara A; Kato N; Torimoto N; Aohara F; Ohashi R; Yamada Y; Taniguchi H
    Drug Metab Lett; 2018; 12(1):14-23. PubMed ID: 29357810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450 induction in rat hepatocytes assessed by quantitative real-time reverse-transcription polymerase chain reaction and the RNA invasive cleavage assay.
    Burczynski ME; McMillian M; Parker JB; Bryant S; Leone A; Grant ER; Thorne JM; Zhong Z; Zivin RA; Johnson MD
    Drug Metab Dispos; 2001 Sep; 29(9):1243-50. PubMed ID: 11502735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes.
    Parkinson A; Mudra DR; Johnson C; Dwyer A; Carroll KM
    Toxicol Appl Pharmacol; 2004 Sep; 199(3):193-209. PubMed ID: 15364537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of 23 lots of commercially available cryopreserved hepatocytes for induction assays of human cytochromes P450.
    Yajima K; Uno Y; Murayama N; Uehara S; Shimizu M; Nakamura C; Iwasaki K; Utoh M; Yamazaki H
    Drug Metab Dispos; 2014 May; 42(5):867-71. PubMed ID: 24553381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up to the pre-validation of a harmonised protocol for assessment of CYP induction responses in freshly isolated and cryopreserved human hepatocytes with respect to culture format, treatment, positive reference inducers and incubation conditions.
    Abadie-Viollon C; Martin H; Blanchard N; Pekthong D; Bachellier P; Mantion G; Heyd B; Schuler F; Coassolo P; Alexandre E; Richert L
    Toxicol In Vitro; 2010 Feb; 24(1):346-56. PubMed ID: 19497360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of induction of cytochrome P450 by NO-1886 (ibrolipim), a lipoprotein lipase-promoting agent, in primary cultures of human hepatocytes and in female rat liver.
    Morioka Y; Nishimura M; Imai T; Suzuki S; Harada M; Satoh T; Naito S
    Drug Metab Pharmacokinet; 2006 Feb; 21(1):19-28. PubMed ID: 16547390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme induction and cytotoxicity in human hepatocytes by chlorpyrifos and N,N-diethyl-m-toluamide (DEET).
    Das PC; Cao Y; Rose RL; Cherrington N; Hodgson E
    Drug Metabol Drug Interact; 2008; 23(3-4):237-60. PubMed ID: 19326769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of honokiol on the induction of drug-metabolizing enzymes in human hepatocytes.
    Cho YY; Jeong HU; Kim JH; Lee HS
    Drug Des Devel Ther; 2014; 8():2137-45. PubMed ID: 25395831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human HepaRG Cells can be Cultured in Hanging-drop Plates for Cytochrome P450 Induction and Function Assays.
    Murayama N; Usui T; Slawny N; Chesné C; Yamazaki H
    Drug Metab Lett; 2015; 9(1):3-7. PubMed ID: 25600204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of gene induction of drug-metabolizing enzymes and transporters in primary culture of human hepatocytes using high-sensitivity real-time reverse transcription PCR.
    Nishimura M; Yoshitsugu H; Naito S; Hiraoka I
    Yakugaku Zasshi; 2002 May; 122(5):339-61. PubMed ID: 12040753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid determination of rat hepatocyte mRNA induction potential using oligonucleotide probes for CYP1A1, 1A2, 3A and 4A1.
    Surry DD; Meneses-Lorente G; Heavens R; Jack A; Evans DC
    Xenobiotica; 2000 May; 30(5):441-56. PubMed ID: 10875679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Screening Criteria Setting on Evaluation of Cytochrome P450 Induction Using HepaRG Cells with Multiplex Branched DNA Technologies in Early Drug Discovery.
    Ogasawara A; Torimoto N; Tsuda N; Aohara F; Ohashi R; Yamada Y; Taniguchi H
    Drug Metab Lett; 2016; 10(3):152-160. PubMed ID: 27550199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the inducibility of CYP mRNA exposed to typical inducers in fresh and cryopreserved cynomolgus monkey hepatocytes.
    Koeda A; Iwao T; Nakanishi A; Mizuno S; Yamashita M; Sakai Y; Nakamura K; Matsunaga T
    Drug Metab Pharmacokinet; 2020 Jun; 35(3):304-312. PubMed ID: 32303457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative RT-PCR measurement of human cytochrome P-450s: application to drug induction studies.
    Rodríguez-Antona C; Jover R; Gómez-Lechón MJ; Castell JV
    Arch Biochem Biophys; 2000 Apr; 376(1):109-16. PubMed ID: 10729196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro assessment of P450 induction potential of novel chemopreventive agents SR13668, 9-cis-UAB30, and pentamethychromanol in primary cultures of human hepatocytes.
    Jackson JP; Kabirov KK; Kapetanovic IM; Lyubimov A
    Chem Biol Interact; 2009 May; 179(2-3):263-72. PubMed ID: 19135037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.